General
Distributor of Competing Drug Asked Health Inspectorate to Act Against Newspapers Writing About Weight Loss Medication
/s3/static.nrc.nl/wp-content/uploads/2026/09/29190643/290926WET_2036942950_apotheek.jpg)
The Dutch Health Inspectorate (IGJ) fined NRC and Volkskrant for allegedly violating advertising bans on prescription weight-loss drugs following a request from Goodlife, distributor of Mysimba. The inspectorate imposed fines totaling tens of thousands of euros on several newspapers, including De Telegraaf and AD. Goodlife’s legal representative argued that media coverage lacked balanced information favoring their product, raising concerns about competitive positioning under the Medicines Act.
Ozetta summarises; the reporting is the newsroom's